ADTX vs TLRY · rev $3.2K vs rev $915.5M
Aditxt Inc. (ADTX) versus Tilray Inc (TLRY) — a side-by-side from cached financials, not a winner call.
Aditxt Inc. (ADTX) is a biotechnology company listed on NASDAQ.
Tilray Inc (TLRY) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported ADTX revenue for 2025-12-31 was $3.2K. Net income was -$43.1M. Revenue was down 97.6% from 2024-12-31 to 2025-12-31. ADTX currently screens at market cap $3.6K.
Latest reported TLRY revenue for 2026-05-31 was $915.5M. Net income was -$121.4M. Revenue was up 11.5% from 2025-05-31 to 2026-05-31. TLRY currently screens at market cap $573.9M.
ADTX currently screens at market cap $3.6K. TLRY currently screens at market cap $573.9M.
Not investment advice. Open the ADTX and TLRY stock pages for the full models.
Not investment advice.